ArticleFrontiers in oncology2023

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.

Ping-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.